|
RACGAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.31189503704832E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.158300E-04 |
| Normal-vs-Stage2 |
4.863800E-02 |
| Normal-vs-Stage3 |
2.42699999999374E-05 |
| Normal-vs-Stage4 |
1.714310E-02 |
| Stage1-vs-Stage2 |
4.335400E-01 |
| Stage1-vs-Stage3 |
1.802910E-03 |
| Stage1-vs-Stage4 |
6.609600E-02 |
| Stage2-vs-Stage3 |
6.088300E-02 |
| Stage2-vs-Stage4 |
1.166440E-01 |
| Stage3-vs-Stage4 |
8.591600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.23439996797026E-09 |
| Normal-vs-AfricanAmerican |
3.392400E-04 |
| Normal-vs-Asian |
5.036100E-02 |
| Caucasian-vs-AfricanAmerican |
9.703800E-01 |
| Caucasian-vs-Asian |
3.346400E-01 |
| AfricanAmerican-vs-Asian |
3.274600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.97219999512555E-08 |
| Normal-vs-Female |
3.86339999991492E-07 |
| Male-vs-Female |
1.122450E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.540900E-03 |
| Normal-vs-Extreme_Weight |
7.883100E-03 |
| Normal-vs-Obese |
1.86869999999617E-05 |
| Normal-vs-Extreme_Obese |
9.613000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.805400E-01 |
| Normal_Weight-vs-Obese |
2.335200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.766300E-02 |
| Extreme_Weight-vs-Obese |
8.398900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.046640E-01 |
| Obese-vs-Extreme_Obese |
5.609300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.683300E-03 |
| Normal-vs-Age(41-60Yrs) |
3.29259997045028E-09 |
| Normal-vs-Age(61-80Yrs) |
2.214900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.336240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.892300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.720350E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.377520E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.368200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.455200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.459200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.04100000000307E-05 |
| Normal-VS-Type2 PRCC |
2.08339999999696E-05 |
| Normal-VS-KIRP CIMP |
1.135380E-03 |
| Normal-VS-Unclassified PRCC |
4.166500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.764200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.697700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.736200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.542000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.841400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.337700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.724600E-03 |
| Normal-vs-N1 |
8.09640000000167E-05 |
| Normal-vs-N2 |
1.306030E-01 |
| N0-vs-N1 |
1.324900E-03 |
| N0-vs-N2 |
7.283700E-02 |
| N1-vs-N2 |
5.867400E-01 |
|
|
